Decrease in DA uptake activity in striatal synaptosomes of <i>Ptprz-</i>KO mice. by Akihiro Fujikawa (122649)

Reduced RAB27A expression in melanocytes significantly decreases the melanin content in the epidermis, resulting in a lighter skin surface color of HSS. by Yasuko Yoshida-Amano (314746)

Data Supplement from Decreased Expression of Cystathionine β-Synthase Promotes Glioma Tumorigenesis by Naoharu Takano (15079957)

Glucocorticoid receptor antagonist RU486 abolished the decreased immune response induced by BPA. by Susanne Petzold (581217)

Decreased mRNA levels of inflammatory cytokines from <i>cpdm</i> BMDC. by Zhe Wang (41178)

Decreased SDF-1 in CSC-mediated cardioprotection following acute I/R injury. by Chunyan Huang (337274)

Anti-TGFβ antibody decreased osteoclast numbers and <i>in vitro</i> osteoclastogenesis. by Swati Biswas (73661)

“…Wilcoxon rank-sum p-value for TGFβ and TGFβ + 1D11 groups is 0.01. Mean ± standard deviation = TGFβ: 26.5±3.83, TGFβ + 1D11: 17.83±4.17. …”

Glucocorticoid receptor antagonist RU486 abolished the decreased immune response induced by BPA. by Susanne Petzold (581217)

Parasite burden is significantly decreased in the small intestine of <i>taiep</i> infected rats. by Karen Elizabeth Nava-Castro (6940340)

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Rapamycin treatment decreases inflammation, endoplasmic reticulum stress and apoptosis markers in obese mice. by Mariana Portovedo (571281)

Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice. by Swati Biswas (73661)

“…(N = at least 5). <b>Panel d:</b> Boxplot of tumor burden by group for the 4T1 tumor bearing mice (4T1 cells injected in Balb/c), treated 1 day post tumor cell injection and treated for 4 weeks shown decrease in tumor burden. …”

Marimastat treatment resulted in decreased adiposity and liver weights and normalized macroscopic appearance of the liver. by Vincent E. de Meijer (343377)

Compound 49b can overcome ischemia/reperfusion-induced decreases in retinal thickness. by Li Liu (75607)

CC genotype of rs7120118 variation associates with decreased soluble Aβ42 levels in the temporal cortex. by Teemu Natunen (398069)

“…<p>(A) The distribution of rs7120118 genotypes in subgroups divided by the severity of the disease (mild n = 19/18/9; moderate n = 4/4/5; severe n = 10/12/2, rs7120118 genotypes TT/CT/CC, respectively). …”

Jurkat and HeLa survival decreases with increasing electric field amplitude and pulse number. by Bennett L. Ibey (357053)

“…Data points represent the average survival. (mean +/−s.e., n = 3–5).</p>…”

Decreased cell growth of PGRN knock-out cell line as determined by the MTT assay. by Weifeng Zhang (134361)

Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

“…(<b>D</b>) Quantification was presented as a relative difference between the AP-covered LP area in controls and mutants (1.00 ± 0.07 for control, 0.20 ± 0.03 for cKO; <i>n</i> = 4 mice/group). …”

Substrate reduction therapy normalizes urine volume and decreases urine GL-3 levels. by John Marshall (39501)

Decreased desaturation of fatty acids in WAT, plasma and liver from HSL null mice. by Céline Fernandez (88202)